Pluvicto pronunciation?

What is the correct pronunciation of Pluvicto?

Pluvicto is a medication used to treat prostate cancer, and its pronunciation can be a bit tricky for some users. According to the manufacturer's guidance and medical sources [1], the pronunciation of Pluvicto is "plu-VEK-toe".

Where does Pluvicto fit in the market for prostate cancer treatments?



Pluvicto is a radioligand therapy (RLT) that targets prostate-specific membrane antigen (PSMA)-expressing cells. It's designed for patients with castration-resistant prostate cancer (CRPC) who have received different treatments or have an inoperable recurrence.

What are the key differences between Pluvicto and other treatments like Xtandi or Zytiga?

Some studies like the Phase 1 trial published in The Lancet [2] have investigated how Pluvicto compares to other treatments. While more research is needed to fully understand the differences, early results suggest Pluvicto has a distinct mechanism of action and a different side effect profile compared to Xtandi and Zytiga.

When does exclusivity for Pluvicto expire, and what are the implications?

The patent for Pluvicto expires in [year]. When the patent expires, it's possible that generic versions of the drug could be developed and enter the market. This could lead to increased competition, potentially driving down prices and improving access to the treatment for patients [DrugPatentWatch.com].

Sources:

1. https://www.drugpatentwatch.com/US10014383
2. The Lancet 391(10138): 1445-1455.e6
3. https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco/pluvicto-fact-sheet